Literature DB >> 11809758

Activation of dynamin I gene expression by Sp1 and Sp3 is required for neuronal differentiation of N1E-115 cells.

Jiyun Yoo1, Moon-Jin Jeong, Byoung-Mog Kwon, Man-Wook Hur, Young-Mee Park, Mi Young Han.   

Abstract

Dynamin I is a key molecule required for the recycling of synaptic vesicles in neurons, and it has been known that dynamin I gene expression is induced during neuronal differentiation. Our previous studies established that neuronal restriction of dynamin I gene expression is controlled by Sp1 and nuclear factor-kappaB-like element-1. Here, using a series of deletion constructs and site-directed mutation, we found that transcription of dynamin I gene during neuronal differentiation of N1E-115 cells is controlled primarily by the Sp1 element located between -13 to -4 bp of the dynamin I promoter. Gel shift analysis demonstrated that in addition to Sp1, Sp3 could interact with this Sp1 element. The requirement for Sp family transcription factors in dynamin I gene expression was confirmed by using mithramycin, an inhibitor of Sp1/Sp3 binding. Mithramycin repressed dynamin I gene expression and resulted in blocking of neuronal differentiation of N1E-115 cells. The localization of the dynamin I protein was also restricted in the peripheral region of the nucleus by the mithramycin treatment. Thus, all of our results suggest that induction of dynamin I gene expression during N1E-115 cell differentiation is modulated by Sp1/Sp3 interactions with the dynamin I promoter, and its expression is important for neuronal differentiation of the N1E-115 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809758     DOI: 10.1074/jbc.M111788200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Bayesian variable selection for gene expression modeling with regulatory motif binding sites in neuroinflammatory events.

Authors:  Kuang-Yu Liu; Xiaobo Zhou; Kinhong Kan; Stephen T C Wong
Journal:  Neuroinformatics       Date:  2006

2.  Amphiphysin 1 is important for actin polymerization during phagocytosis.

Authors:  Hiroshi Yamada; Emiko Ohashi; Tadashi Abe; Norihiro Kusumi; Shun-Ai Li; Yumi Yoshida; Masami Watanabe; Kazuhito Tomizawa; Yuji Kashiwakura; Hiromi Kumon; Hideki Matsui; Kohji Takei
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

3.  Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease.

Authors:  Brent L Kelly; Robert Vassar; Adriana Ferreira
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

4.  Genomic structure and cloning of two transcript isoforms of human Sp8.

Authors:  Maria-athina Milona; Julie E Gough; Alasdair J Edgar
Journal:  BMC Genomics       Date:  2004-11-08       Impact factor: 3.969

5.  AMPH-1 As A Critical Tumor Suppressor That Inhibits Osteosarcoma Progression.

Authors:  Haiyun Zhang; Yujie Liu; Kehan Xu; Kai Mao; Weidong Han; Feifan Xu; Wei Wan; Yajun Sun
Journal:  Cancer Manag Res       Date:  2019-11-25       Impact factor: 3.989

6.  Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer.

Authors:  Long G Wang; Anna C Ferrari
Journal:  Transl Oncogenomics       Date:  2006-10-11

7.  The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system.

Authors:  Paula García-Huerta; Miguel Díaz-Hernandez; Esmerilda G Delicado; María Pimentel-Santillana; M Teresa Miras-Portugal; Rosa Gómez-Villafuertes
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

8.  Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells.

Authors:  Maria-athina Milona; Julie E Gough; Alasdair J Edgar
Journal:  BMC Genomics       Date:  2003-11-07       Impact factor: 3.969

9.  AMPH-1 is critical for breast cancer progression.

Authors:  Yajun Chen; Jian Liu; Lei Li; Hefeng Xia; Zaijun Lin; Tianying Zhong
Journal:  J Cancer       Date:  2018-05-25       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.